Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL)

Q: What does CUSIP 05280R100 represent in this 13F holders report?

CUSIP 05280R100 is the security identifier for AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share used to aggregate holder disclosures.

Q: How many institutions held AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share in Q1 2021?

58 institutional investors reported AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share for Q1 2021. Use the holders table for investor-level position and value details.

CUSIP: 05280R100

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / American Depositary Shares, each representing one ordinary share, par value $0.000042 per share
Shares outstanding: 265,957,447
Total 13F shares: 22,400,702
Share change: +9,806,691
Total reported value: $128,321,739
Price per share: $5.73
Number of holders: 58
Value change: +$53,655,759
Number of buys: 38
Number of sells: 14

Quarterly Holders Quick Answers

What is CUSIP 05280R100?
CUSIP 05280R100 identifies AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 05280R100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital World Investors	13F	Company	1.1%	2,955,806	$26,425,000	—	31 Dec 2020	13F
Tetragon Partners GP Ltd	13F	Company	0.81%	2,150,000	$19,221,000	—	31 Dec 2020	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.63%	1,672,732	$14,954,000	—	31 Dec 2020	13F
Capital International Investors	13F	Company	0.46%	1,222,688	$10,931,000	—	31 Dec 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	0.29%	782,183	$6,993,000	—	31 Dec 2020	13F
Alphabet Inc.	13F	Company	0.26%	698,262	$6,242,000	—	31 Dec 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.21%	570,455	$5,100,000	—	31 Dec 2020	13F
Granahan Investment Management, LLC	13F	Company	0.18%	465,795	$4,164,000	—	31 Dec 2020	13F
Cormorant Asset Management, LP	13F	Company	0.16%	422,167	$3,774,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	0.11%	300,260	$2,684,000	—	31 Dec 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.1%	254,260	$2,273,000	—	31 Dec 2020	13F
Alyeska Investment Group, L.P.	13F	Company	0.06%	165,809	$1,482,000	—	31 Dec 2020	13F
Eversept Partners, LP	13F	Company	0.06%	154,981	$1,385,530	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.05%	129,208	$1,155,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	0.04%	112,767	$1,008,000	—	31 Dec 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.03%	80,956	$724,000	—	31 Dec 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.03%	79,120	$707,000	—	31 Dec 2020	13F
Pendal Group Ltd	13F	Company	0.02%	50,354	$450,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.02%	44,417	$397,000	—	31 Dec 2020	13F
MPM BioImpact LLC	13F	Company	0.01%	39,740	$355,000	—	31 Dec 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	34,323	$307,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.01%	30,873	$276,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	26,739	$239,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	0.01%	22,534	$201,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.01%	19,008	$170,000	—	31 Dec 2020	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.01%	18,526	$166,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.01%	15,783	$141,000	—	31 Dec 2020	13F
Burrage Capital Management LLC	13F	Company	0.01%	15,006	$134,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.01%	14,385	$129,000	—	31 Dec 2020	13F
Aperio Group, LLC	13F	Company	0%	12,419	$111,000	—	31 Dec 2020	13F
Legal & General Group Plc	13F	Company	0%	10,891	$97,000	—	31 Dec 2020	13F
UBS Group AG	13F	Company	0%	5,544	$50,000	—	31 Dec 2020	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	5,100	$46,000	—	31 Dec 2020	13F
American Portfolios Advisors	13F	Company	0%	4,750	$42,465	—	31 Dec 2020	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	1,612	$14,000	—	31 Dec 2020	13F
RBC Europe Ltd	13F	Company	0%	1,400	$12,516	—	31 Dec 2020	13F
CITIGROUP INC	13F	Company	0%	1,017	$9,000	—	31 Dec 2020	13F
CONCOURSE FINANCIAL GROUP SECURITIES, INC.	13F	Company	0%	1,000	$9,000	—	31 Dec 2020	13F
Penserra Capital Management LLC	13F	Company	0%	795	$7,000	—	31 Dec 2020	13F
Lindbrook Capital, LLC	13F	Company	0%	607	$5,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	564	$5,000	—	31 Dec 2020	13F
US BANCORP \DE\	13F	Company	0%	539	$5,000	—	31 Dec 2020	13F
Parallel Advisors, LLC	13F	Company	0%	229	$2,000	—	31 Dec 2020	13F
Derivatives Exane	13F	Individual	0%	180	$1,609	—	31 Dec 2020	13F
BARCLAYS PLC	13F	Company	0%	148	$1,000	—	31 Dec 2020	13F
ROYAL BANK OF CANADA	13F	Company	0%	114	$1,000	—	31 Dec 2020	13F
Daiwa Securities Group Inc.	13F	Company	0%	74	$1,000	—	31 Dec 2020	13F

Institutional Holders of Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) as of Q1 2021

As of 31 Mar 2021, Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,400,702 shares. The largest 10 holders included Capital World Investors, Polygon Management Ltd., Capital International Investors, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Opaleye Management Inc., FMR LLC, SCHRODER INVESTMENT MANAGEMENT GROUP, Ikarian Capital, LLC, Alphabet Inc., and JPMORGAN CHASE & CO. This page lists 58 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.